![](/img/cover-not-exists.png)
A 4-week versus a 3-week schedule of gemcitabine monotherapy for advanced pancreatic cancer: a randomized phase II study to evaluate toxicity and dose intensity
Ken Hirao, Hirofumi Kawamoto, Ichiro Sakakihara, Yasuhiro Noma, Naoki Yamamoto, Ryo Harada, Koichiro Tsutsumi, Masakuni Fujii, Hironari Kato, Naoko Kurihara, Osamu Mizuno, Tsuneyoshi Ogawa, Etsuji IshVolume:
16
Language:
english
Pages:
9
DOI:
10.1007/s10147-011-0237-z
Date:
December, 2011
File:
PDF, 348 KB
english, 2011